Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Instagram Outage Disrupts Thousands of U.S. Users 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
TEANECK, N.J., Oct. 03, 2017 -- Phibro Animal Health Corporation (NASDAQ:PAHC) will host a webcast and conference call to review its first quarter financial results. Phibro expects to issue a news release containing quarterly results after the market closes on Monday, November 6, 2017.
Details for the webcast and conference call:
| Date: | Tuesday, November 7, 2017 | ||
| Time: | 9:00 AM Eastern Time | ||
| Location: | http://investors.pahc.com | ||
| U.S. Toll-Free: | +1 (877) 853-5634 | ||
| International Toll: | +1 (315) 625-6893 | ||
| Conference ID: | 93299558 | ||
Note: In order to join this conference call, participants will be required to provide the Conference ID number.
Archive: A replay of the webcast and conference call will be available on Phibro’s website.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $764 million for the fiscal year ended June 30, 2017. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact:
Richard Johnson
Phibro Animal Health Corporation
Chief Financial Officer
+1-201-329-7300
[email protected]
